Location History:
- Munich, DE (1991)
- Munchen, DE (2000)
- München, DE (2005 - 2015)
Company Filing History:
1 out of 118 
1 out of 507 
1 out of 2 
Years Active: 1991-2015
Title: Josef Weigl: Innovator in Vaccine Development and Paper Finishing
Introduction
Josef Weigl is a notable inventor based in Munich, Germany. He has made significant contributions to the fields of vaccine development and surface finishing technologies. With a total of 4 patents to his name, Weigl's work has had a meaningful impact on public health and industrial processes.
Latest Patents
One of Weigl's latest patents is the "Recombinant modified vaccinia virus Ankara influenza vaccine." This invention involves a recombinant modified vaccinia virus Ankara (MVA virus) that expresses at least two external influenza virus antigens and/or an epitope of one or more of these antigens, as well as at least two internal influenza virus antigens. The invention aims to create a recombinant MVA virus encoding multiple antigens from various influenza virus strains, which can be used in preparing a medicament and vaccine for influenza. Additionally, the invention encompasses methods, compositions, and kits related to this vaccine.
Another significant patent by Weigl is focused on the "Surface finishing of paper or board." This patent describes a method for applying an aqueous solution of a surface-finishing active ingredient to a hydrophilic paper or board sheet. This innovation enhances the quality and functionality of paper products, making them more suitable for various applications.
Career Highlights
Throughout his career, Josef Weigl has worked with several prominent companies, including Sud-Chemie AG and Clariant Finance (BVI) Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in both vaccine technology and material science.
Collaborations
Weigl has collaborated with notable professionals in his field, including Axel Von Raven and Friedrich Ruf. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Josef Weigl's contributions to vaccine development and paper finishing technologies demonstrate his innovative spirit and commitment to improving public health and industrial processes. His patents reflect a deep understanding of complex scientific principles and a dedication to practical applications.